The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection

Journal of Viral Hepatitis

Volumn 21, Issue 7, 2014, Pages 517-524

  Papatheodoridis, G V ^a   Manolakopoulos, S ^a   Margariti, A ^a   Papageorgiou, M V ^a   Kranidioti, H ^a   Katoglou, A ^a   Kontos, G ^a   Adamidi, S ^a   Kafiri, G ^b   Deutsch, M ^a   Pectasides, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

chronic hepatitis B; elastography; HBV DNA; inactive carriers; liver biopsy

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; DIFFERENTIATION; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATOBILIARY PARAMETERS; HUMAN; LIVER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RIGIDITY; STAGING; VIREMIA; AGED; BLOOD; COMPLICATION; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ADULT; AGED; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84902277969     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12176     Document Type: Article

References (32)

1. Hadziyannis SJ, Papatheodoridis GV,. Hepatitis Be antigen negative chronic hepatitis B-natural history and treatment. Semin Liver Dis 2006; 26: 130-141.
2. Papatheodoridis GV, Hadziyannis SJ,. Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat 2001; 8: 311-321.
3. Manesis E, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ,. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003; 98: 2261-2267.
4. Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK,. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. J Viral Hepat 2008; 15: 434-441.
5. Papatheodoridis GV, Manesis EK, Manolakopoulos S, et al,. Is there a meaningful serum HBV DNA cut-off level for therapeutic decisions in HBeAg-negative chronic hepatitis B virus infection? Hepatology 2008; 48: 1451-1459.
6. Papatheodoridis GV, Manolakopoulos S, Liaw Y-F, Lok A,. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. J Hepatol 2012; 57: 196-202.
7. Papatheodoridis GV,. Ethics related to liver biopsies and antiviral therapies in chronic viral hepatitis. Dig Dis 2008; 26: 59-65.
8. Castera L,. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012; 142: 1293-1302.
9. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK,. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-659.
10. Paraskevis D, Haida C, Tassopoulos N, et al,. Development and assessment of a novel real-time PCR assay quantitation of HBV-DNA. J Virol Methods 2002; 103: 201-212.
11. Ishak K, Baptista A, Bianchi L, et al,. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
12. Castera L, Bernard PH, Le BB, et al,. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther 2011; 33: 455-465.
13. Sporea I, Nicolita D, Sirli R, Deleanu A, Tudora A, Bota S,. Assessment of noninvasive liver stiffness in inactive HBsAg carriers by transient elastography: Fibroscan in inactive HBsAg carriers. Hepat Mon 2011; 11: 182-185.
14. Oliveri F, Coco B, Ciccorossi P, et al,. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol 2008; 14: 6154-6162.
15. Marcellin P, Ziol M, Bedossa P, et al,. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-247.
16. Kim DY, Kim SU, Ahn SH, et al,. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009; 54: 1758-1763.
17. Enomoto M, Mori M, Ogawa T, et al,. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: regression of liver stiffness during entecavir therapy. Hepatol Res 2010; 40: 853-861.
18. Zhu X, Wang LC, Chen EQ, et al,. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci 2011; 56: 2742-2749.
19. Andersen ES, Weiland O, Leutscher P, et al,. Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs. Scand J Gastroenterol 2011; 46: 760-766.
20. Lim SG, Cho SW, Lee YC, et al,. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B. Hepatogastroenterology 2011; 58: 539-545.
21. Lesmana CR, Salim S, Hasan I, et al,. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting. J Clin Pathol 2011; 64: 916-920.
22. Fung J, Lai CL, Wong DK, Seto WK, Hung I, Yuen MF,. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. J Viral Hepat 2011; 18: e200-e205.
23. Osakabe K, Ichino N, Nishikawa T, et al,. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol 2011; 46: 1324-1334.
24. Ogawa E, Furusyo N, Murata M, et al,. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog. Hepatol Res 2011; 41: 1178-1188.
25. Verveer C, Zondervan PE, ten Kate FJ, Hansen BE, Janssen HL, de Knegt RJ,. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int 2012; 32: 622-628.
26. Chen YP, Liang XE, Zhang Q, et al,. Larger biopsies evaluation of transient elastography for detecting advanced fibrosis in patients with compensated chronic hepatitis B. J Gastroenterol Hepatol 2012; 27: 1219-1226.
27. Kim BK, Kim SU, Kim HS, et al,. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS ONE 2012; 7: e35825.
28. Xie L, Chen X, Guo Q, Dong Y, Guang Y, Zhang X,. Real-time Elastography for Diagnosis of Liver Fibrosis in Chronic Hepatitis B. J Ultrasound Med 2012; 31: 1053-1060.
29. Cardoso AC, Carvalho-Filho RJ, Stern C, et al,. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 2012; 32: 612-621.
30. Papageorgiou MV, Papatheodoridis GV, Manolakopoulos S, et al,. Elastography for hepatic fibrosis severity in chronic hepatitis B or C. Case Rep Gastroenterol 2011; 5: 63-72.
31. Chan HL, Wong GL, Choi PC, et al,. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16: 36-44.
32. Arena U, Vizzutti F, Corti G, et al,. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-384.